Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,406,587
-
Share change
-
+2,205,974
-
Total reported value
-
$68,195,600
-
Put/Call ratio
-
39%
-
Price per share
-
$7.25
-
Number of holders
-
56
-
Value change
-
+$7,059,436
-
Number of buys
-
41
-
Number of sells
-
12
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2021
As of 31 Dec 2021,
Humacyte, Inc. - COM (HUMA) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,406,587 shares.
The largest 10 holders included
York Capital Management Global Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, Monashee Investment Management LLC, Diameter Capital Partners LP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Gladstone Institutional Advisory LLC, and UBS Group AG.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.